Translational Research Describes an Epigenetic Approach for Regulating Fear-Memory - PR Newswire

8/22/2022 12:00:00 AM2 years 8 months ago

/PRNewswire/ -- EpiVario, Inc., an emerging biotech company developing novel therapeutics for memory-related psychiatric disorders, today highlighted...

In vivo preclinical research findings from EpiVario and its co-founders describe a novel approach for reducing fear memories, which underly Post-Traumatic Stress Disorder PHILADELPHIA, Aug. 22, 2022… [+7145 chars]

full article...